APRE logo

Aprea Therapeutics (APRE) Accounts Receivable

Annual Accounts Receivable

N/A

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

APRE Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9600.00
APRE annual accounts receivable is currently at an all-time high

3-Year Low

-
APRE annual accounts receivable 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
APRE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 26, 2025
APRE next annual earnings announcement is scheduled for Mar 26, 2025

OtherAPREbalance sheetmetrics:

Annual Accounts Payable

$1.67 M
APRE annual accounts payable is $1.67 million

Annual Total Assets

$22.65 M
APRE annual total assets is $22.65 million

Annual Total Liabilities

$5.70 M
APRE annual total liabilities is $5.70 million

Annual Cash & Cash Equivalents

$21.61 M
APRE annual cash & cash equivalents is $21.61 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

APRE Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

APRE Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Aprea Therapeutics Accounts Receivable History

DateAnnualQuarterly
Jun 2008
$8400.00(-12.5%)
-
DateAnnualQuarterly
Jun 2006
$9600.00
-

FAQ

  • What is the all time high annual accounts receivable for Aprea Therapeutics?

What is the all time high annual accounts receivable for Aprea Therapeutics?

Aprea Therapeutics all-time high annual accounts receivable is $9600.00